Innovent Biologics (HK:1801) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Innovent Biologics, Inc. has announced its current Board of Directors, comprised of executive and independent non-executive members, including Dr. De-Chao Michael Yu as Chairman and CEO. The company also outlined the composition of its four Board committees – Audit, Remuneration, Nomination, and Strategy – detailing the roles and chairmanships held by various directors.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.